Patents by Inventor Francesca Crawford

Francesca Crawford has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Ophthalmic compositions
    Patent number: 9931428
    Abstract: The present invention relates to compositions and methods for eye and contact lens care. More particularly, the invention relates to ophthalmic compositions which contain at least one bioflavonoid component for ocular care, preserving ophthalmic solutions and/or disinfecting contact lenses.
    Type: Grant
    Filed: June 13, 2011
    Date of Patent: April 3, 2018
    Assignee: ORALDENT LIMITED
    Inventors: Francesca Crawford, Philip Gunning, Howard Thomas
  • OPHTHALMIC FORMULATIONS
    Publication number: 20140255332
    Abstract: There is provided inter alia a germicidal aqueous formulation, suitable for use in the eye, which has a pH of from 4.0 to 6.5 and which comprises 4.0 to 7.5% w/w of povidone-iodine and a viscosity increasing agent, the formulation buffered with a buffer concentration of 25 mM to 75 mM.
    Type: Application
    Filed: August 24, 2012
    Publication date: September 11, 2014
    Applicant: Altacor Limited
    Inventors: Francesca Crawford, Philip Gunning
  • OPHTHALMIC COMPOSITIONS
    Publication number: 20140186474
    Abstract: The present invention relates to compositions and methods for eye and contact lens care. More particularly, the invention relates to ophthalmic compositions which contain at least one bioflavonoid component for ocular care, preserving ophthalmic solutions and/or disinfecting contact lenses.
    Type: Application
    Filed: June 13, 2011
    Publication date: July 3, 2014
    Applicant: ORALDENT LIMITED
    Inventors: Francesca Crawford, Philip Gunning, Howard Thomas
  • Methods to identify therapeutic candidates
    Publication number: 20070154906
    Abstract: The invention provides systematic methods for identification of candidate compounds useful in treatment of conditions initiated or modulated by genetic expression. The methods of the invention permit efficient identification of candidates suitable for verification testing by in vitro and/or in vivo models.
    Type: Application
    Filed: October 5, 2006
    Publication date: July 5, 2007
    Applicant: Spirogen Ltd.
    Inventors: Christopher Martin, Philip Howard, David Thurston, John Hartley, Francesca Crawford